Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Endeavor BioMedicines reveals encouraging results for ENV-101 in Phase 2a idiopathic pulmonary fibrosis trial Endeavor BioMedicines, a clinical-stage biotechnology company, has announced encouraging results from their completed Phase 2a clinical trial of… byPallavi MadhirajuMay 20, 2024